These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6690350)

  • 1. Spontaneous reactivation of chronic hepatitis B virus infection.
    Davis GL; Hoofnagle JH; Waggoner JG
    Gastroenterology; 1984 Feb; 86(2):230-5. PubMed ID: 6690350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized controlled trial of adenine arabinoside monophosphate for chronic type B hepatitis.
    Hoofnagle JH; Hanson RG; Minuk GY; Pappas SC; Schafer DF; Dusheiko GM; Straus SE; Popper H; Jones EA
    Gastroenterology; 1984 Jan; 86(1):150-7. PubMed ID: 6196251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels.
    Chu CM; Hung SJ; Lin J; Tai DI; Liaw YF
    Am J Med; 2004 Jun; 116(12):829-34. PubMed ID: 15178498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of short-term prednisone therapy on aminotransferase levels and hepatitis B virus markers in chronic type B hepatitis.
    Rakela J; Redeker AG; Weliky B
    Gastroenterology; 1983 May; 84(5 Pt 1):956-60. PubMed ID: 6832570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precore wild-type DNA and immune complexes persist in chronic hepatitis B after seroconversion: no association between genome conversion and seroconversion.
    Maruyama T; Kuwata S; Koike K; Iino S; Yasuda K; Yotsuyanagi H; Moriya K; Maekawa H; Yamada H; Shibata Y; Milich DR
    Hepatology; 1998 Jan; 27(1):245-53. PubMed ID: 9425944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive factors for reactivation of hepatitis B following hepatitis B e antigen seroconversion in chronic hepatitis B.
    Chu CM; Liaw YF
    Gastroenterology; 2007 Nov; 133(5):1458-65. PubMed ID: 17935720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low frequency of precore hepatitis B virus mutants in anti-hepatitis B e-positive reactivation after loss of hepatitis B e antigen in patients with chronic hepatitis B.
    Loriot MA; Marcellin P; Talbodec N; Guigonis V; Gigou M; Boyer N; Bezeaud A; Erlinger S; Benhamou JP
    Hepatology; 1995 Mar; 21(3):627-31. PubMed ID: 7875659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B.
    Hsu YS; Chien RN; Yeh CT; Sheen IS; Chiou HY; Chu CM; Liaw YF
    Hepatology; 2002 Jun; 35(6):1522-7. PubMed ID: 12029639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis E virus as an etiology of acute exacerbation of previously unrecognized asymptomatic patients with hepatitis B virus-related chronic liver disease.
    Kumar M; Sharma BC; Sarin SK
    J Gastroenterol Hepatol; 2008 Jun; 23(6):883-7. PubMed ID: 18070014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and histological events preceding hepatitis B e antigen seroconversion in chronic type B hepatitis.
    Liaw YF; Chu CM; Su IJ; Huang MJ; Lin DY; Chang-Chien CS
    Gastroenterology; 1983 Feb; 84(2):216-9. PubMed ID: 6848402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic asymptomatic HBSAg carriers: histologic abnormalities and diagnostic and prognostic value of serologic markers of the HBV.
    De Franchis R; D'Arminio A; Vecchi M; Ronchi G; Del Ninno E; Parravicini A; Ferroni P; Zanetti AR
    Gastroenterology; 1980 Sep; 79(3):521-7. PubMed ID: 7429112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus genotypes and spontaneous hepatitis B e antigen seroconversion in Taiwanese hepatitis B carriers.
    Kao JH; Chen PJ; Lai MY; Chen DS
    J Med Virol; 2004 Mar; 72(3):363-9. PubMed ID: 14748059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High rate of mutations in the hepatitis B core gene during the immune clearance phase of chronic hepatitis B virus infection.
    Bozkaya H; Ayola B; Lok AS
    Hepatology; 1996 Jul; 24(1):32-7. PubMed ID: 8707278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship of hepatitis B e antigen, DNA polymerase activity, and titer of hepatitis B surface antigen with ongoing liver injury in chronic hepatitis B virus infection.
    Perrillo R; Campbell C; Wellinghoff W; Gelb L
    Am J Gastroenterol; 1982 Jul; 77(7):445-9. PubMed ID: 7091131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of highly active antiretroviral therapy (HAART) on the natural history of hepatitis B virus (HBV) and HIV coinfection: relationship between prolonged efficacy of HAART and HBV surface and early antigen seroconversion.
    Miailhes P; Trabaud MA; Pradat P; Lebouché B; Chevallier M; Chevallier P; Zoulim F; Trepo C
    Clin Infect Dis; 2007 Sep; 45(5):624-32. PubMed ID: 17682999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenine arabinoside therapy in HBsAg-positive chronic liver disease: a controlled study.
    Bassendine MF; Chadwick RG; Salmeron J; Shipton U; Thomas HC; Sherlock S
    Gastroenterology; 1981 May; 80(5 pt 1):1016-22. PubMed ID: 7009310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up of interferon alfa treatment in Chinese patients with chronic hepatitis B infection: The effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications.
    Yuen MF; Hui CK; Cheng CC; Wu CH; Lai YP; Lai CL
    Hepatology; 2001 Jul; 34(1):139-45. PubMed ID: 11431745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of the precore mutant late in chronic hepatitis B infection correlates with the severity of liver injury and mutations in the core region.
    Maruyama T; Mitsui H; Maekawa H; Yamada H; Hirayama M; Iino S; Yasuda K; Koike K; Kimura S; Milich DR
    Am J Gastroenterol; 2000 Oct; 95(10):2894-904. PubMed ID: 11051365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and histological outcome after hepatitis B e antigen to antibody seroconversion in children with chronic hepatitis B.
    Ruiz-Moreno M; Otero M; Millán A; Castillo I; Cabrerizo M; Jiménez FJ; Oliva H; Ramon y Cajal S; Carreño V
    Hepatology; 1999 Feb; 29(2):572-5. PubMed ID: 9918937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A three-month course of lamivudine therapy in HBeAg-positive hepatitis B patients with normal aminotransferase levels.
    Yalçin K; Değertekin H; Kokoğlu OF; Ayaz C
    Turk J Gastroenterol; 2004 Mar; 15(1):14-20. PubMed ID: 15264116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.